Navigation Links
CuraGen to Present at the BIO CEO & Investor Conference
Date:2/12/2008

BRANFORD, Conn., Feb. 12 /PRNewswire-FirstCall/ -- CuraGen Corporation (Nasdaq: CRGN) announced today that Timothy M. Shannon, M.D., President and Chief Executive Officer, will present at the BIO CEO & Investor Conference on Wednesday, February 13, 2008, at 3:30 p.m. Eastern Standard Time.

Access to a live webcast of the presentation will be available at http://www.curagen.com. A replay of the webcast will be accessible beginning one hour after the presentation and available on the Company's website until March 13, 2008.

About CuraGen

CuraGen Corporation (Nasdaq: CRGN) is a dedicated clinical-stage biopharmaceutical company developing diverse approaches for the treatment of cancer including the histone deacetylase inhibitor, belinostat, and the antibody-drug conjugate, CR011-vcMMAE. By leveraging drug development strengths cultivated over the years, CuraGen expects to make a difference by advancing its promising therapeutics to address the unmet medical needs of cancer patients. CuraGen Corporation is headquartered in Branford, Connecticut. For additional information please visit http://www.curagen.com.

Contacts:

Glenn Schulman, PharmD

Director of Investor Relations

gschulman@curagen.com

(888) 436-6642

CRGN-G


'/>"/>
SOURCE CuraGen Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. CuraGen Reports Fourth Quarter and Year End 2007 Financial Results
2. CuraGen Corporation Receives Notification from NASDAQ
3. CuraGen Corporation Announces Appointment of Sean Cassidy as CFO
4. CuraGen and TopoTarget Announce Initiation of an NCI-sponsored Phase II Clinical Trial of Belinostat for Thymoma and Thymic Carcinoma
5. CuraGen to Present at the 19th Annual Piper Jaffray Health Care Conference
6. CuraGen Appoints Clinical Oncologist as VP of Medical Development
7. CuraGen Corporation Announces Appointment of Dr. Timothy M. Shannon as President and Chief Executive Officer
8. Maxygen to Present at the Roth 20th Annual OC Growth Stock Conference
9. SemBioSys to present at the 10th Annual BIO CEO & Investor Conference
10. Santaris Pharma to Present at 10th Annual Biotechnology Industry Organisation CEO & Investor Conference - February 11th, 2008
11. Emisphere Technologies to Web Cast BIO CEO & Investor Conference Presentation February 12
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/28/2017)... , June 28, 2017 Spectrecology LLC has ... their STEM education and research dollars. The program is ... latest fiber optic spectroscopy and photonics equipment despite current ... Innovations in Spectroscopy ... of equipment purchases used for the classroom or research. ...
(Date:6/28/2017)... ... June 28, 2017 , ... ... Bock UK Ltd (Bock) announced a strategic partnership where Bock will demonstrate ... technology, OPTIMASH® AD-100, has been shown to help biogas producers in the agricultural ...
(Date:6/27/2017)... ... 27, 2017 , ... The recent vote by the American Medication Association to ... hope to patients and hopefully sheds new light on the way health insurers, governments ... expert and founding partner of Texas Fertility Center . , “This designation ...
(Date:6/27/2017)... ... 27, 2017 , ... Indiana-based Xylogenics announced today the release ... process. The efficiencies created by the newest strain design will have an ... industry wherein individual production plants are planning to invest upwards of $350 million ...
Breaking Biology Technology:
(Date:3/30/2017)... , March 30, 2017 Trends, opportunities ... (physiological and behavioral), by technology (fingerprint, AFIS, iris recognition, ... recognition, and others), by end use industry (government and ... immigration, financial and banking, and others), and by region ... , Asia Pacific , and ...
(Date:3/27/2017)... , March 27, 2017  Catholic Health Services ... Management Systems Society (HIMSS) Analytics for achieving Stage ... Model sm . In addition, CHS previously earned ... hospitals using an electronic medical record (EMR). ... high level of EMR usage in an outpatient ...
(Date:3/23/2017)... 23, 2017 The report "Gesture Recognition and Touchless Sensing ... Geography - Global Forecast to 2022", published by MarketsandMarkets, the market is expected ... 29.63% between 2017 and 2022. Continue Reading ... ... ...
Breaking Biology News(10 mins):